Griaule Biometrics has released their new version of their biometric cloud service the Griaule Biometric Framework 2.0. Version 2.0 now supports the ability to enroll fingerprints, face, and voice. The goal of this software is to help developers easily integrate biometric support into any application.
Griaule Biometrics has partnered with Diebold, and Lumidigm to provide biometric fingerprint recognition for Caixa Economica Federal ATMs in Brazil. The goal is to provide Caixa 58 million customers with a safe and easy process to access their bank accounts at electronic terminals that does not rely on a password.
By long-term providing DNA plasmid under GLP condition for our in-house downstream services, such as transient protein expression, stable cell line construction, and antibody drug development, GenScript has established superior laboratory for GLP service that other suppliers cannot achieve.
Shafique Virani, Global Head of CNS Business Development & Licensing at F. Hoffmann-La Roche will give a featured presentation on the "Role of Business Development in Building and Enabling a World Class CNS Portfolio" at the 5th CNS Partnering and Deal-making Conference to be held in San Francisco, CA on September 13-14, 2012.
Lubor Gaal, Head of Strategic Transactions Group, Europe, at Bristol-Myers Squibb, will give a featured presentation at the 5th CNS Partnering and Deal-making Conference (Sept 13-14, 2012 in San Francisco, CA).
Pradeep Nathan, Director of Neuroscience at GlaxoSmithKline, will give a featured presentation on 'What is the Value of Functional Imaging in Early Clinical Development?' at GTC's Neurological Biomarkers conference (Sept 6th-7th, 2012 in Zurich, Switzerland).
Stephen Brannan, Vice President and Therapeutic Area Leader for Neuroscience, Clinical Science at Takeda Global Research & Development [TGRD] will give a plenary keynote presentation at the 2nd CNS Diseases World Summit taking place on Sept 13-14, 2012 in San Francisco, CA.
The Dow Chemical Company & OPX Biotechnologies to give a Joint Presentation at the 3rd Biobased Chemicals: Commercialization & Partnering Conference (Sep 13-14, 2012 in San Francisco, CA).
Dave Shelton, Senior Director at Pfizer Global Research & Development will give a featured presentation about NGF Inhibitors for Pain at the Pain Research and Therapeutics Conference (Sept 13-14, 2012 in San Francisco, CA).
Michael W. Weiner, Professor at UCSF and Director at DVA Medical Center San Francisco will give a featured presentation at the 6th Neurodegenerative Conditions Research and Development conference (Sep 13-14, 2012 • San Francisco, CA).
Chas Bountra, Chief Scientist at Structural Genomics Consortium will give a presentation at the Pain Research and Therapeutics Conference (Sept 13-14, 2012 in San Francisco, CA).
Mark M. Goodman, Professor of Radiology and Imaging Sciences, Psychiatry and Hematology and Oncology at Emory University will give a presentation on the "Development of Radiolabeled Monoamine Transporter Ligands to Study Neuropsychiatric Disorders" at the 2nd Neuropsychiatric Research and Development conference taking place on Sept 13-14, 2012 in San Francisco, CA.
Lennart Mucke, Director at the Gladstone Institute of Neurological Disease and a Professor at UCSF will give a presentation on "Experimental Strategies to Prevent and Reverse Neural Network Dysfunction in Alzheimer's Disease" at the 6th Neurodegenerative Conditions Research and Development conference taking place on Sept 13-14, 2012 in San Francisco, CA.
GTC is pleased to welcome representatives of AstraZeneca, Eli Lilly, GlaxoSmithKline and Novartis Pharmaceuticals as speakers at the Biotechnology Transfer & Commercialization Conference.
Barry Brand, Chief Executive Officer & Director at CeNeRx will give a plenary keynote presentation at the 2nd CNS Diseases World Summit (Sept 13-14, 2012 in San Francisco, CA).
Paul Nowatzki, Ph.D., Senior Associate Scientist and Innovation Manager at Bayer MaterialScience will give a Presentation entitled, "Polymer Company Perspective on Biobased Chemicals: Opportunities and Challenges" at the 3rd Biobased Chemicals: Commercialization & Partnering Conference on September 13-14, 2012 in San Francisco, CA.
Radon Mitigation Atlanta is now offering home and business owners a number of ways to ensure their safety. Radon is a radioactive element that is extremely toxic. It is a colorless, odorless gas that is derived from the decay of radium. Radon Mitigation Atlanta GA can test properties for the presence of the toxic gas. For FREE information about radon gas, call 1-800-NO-RADON or (404) 522-9708.
Avacta Group - a UK-based healthcare technology and consumables business - has expanded its Yorkshire headquarters with the addition of new laboratory, office and manufacturing space.
Charles B. Nemeroff, Leonard M. Miller Professor, Chairman and Director at the University of Miami will give a plenary keynote presentation on "Obstacles in Drug Development" at the 2nd CNS Diseases World Summit taking place on Sept 13-14, 2012 in San Francisco, CA.
James Merson, Senior Vice President, Head of Vaccine Research West at Pfizer, will be giving a featured presentation on the "Development of a Peptide Conjugate Vaccine for Inducing Anti-IgE Antibodies to Treat Asthma" at the 10th Vaccines Research & Development: All Things Considered Conference on July 9th-10th, 2012 in San Francisco, CA by GTC.
Yoshihiro Kawaoka, will be giving a keynote presentation entitled "An Epic Journey to Publish Ferret H5N1 Transmission Studies" at the Influenza Research and Development Conference on July 9th-10th, 2012 in San Francisco, CA by GTC.
Peter Palese, Professor and Chair, Department of Microbiology, Mount Sinai School of Medicine, will be giving a keynote presentation entitled "A Universal Influenza Virus Vaccine" at the Influenza Research and Development Conference on July 9th-10th, 2012 in San Francisco, CA by GTC.
Tecan has signed a co-marketing agreement with Reinnervate, a leading company in the 3D cell culture market, to develop a range of automated solutions based on the Freedom EVO® liquid handling workstations and Reinnervate's Alvetex®Scaffold 3D cell culturing technology.
Brad Spellberg, Associate Professor of Medicine at UCLA Medical Center will give a keynote presentation on "The Future of Antibiotic R&D" at the 9th Anti-Infectives Partnering and Deal-making Conference taking place on July 9-10, 2012 in San Francisco, CA.
Maureen Gibbons, who serves as senior corporate counsel at Bristol-Myers Squibb Co., will join the Life Science Legal & Business Strategy Conference as a speaker, GTC has announced. The conference is scheduled June 7-8, 2012 at the Hilton San Diego Resort & Spa.
Joseph Larsen, Chief of Broad Spectrum Antimicrobials (BSA) Program and Division of CBRN Countermeasures at DHHS / ASPR / BARDA will give a featured presentation about Partnering and Working with BARDA at the 9th Anti-Infectives Partnering and Deal-making Conference taking place on July 9-10, 2012 in San Francisco, CA.
Satisfied Users & 
Approved Press Releases
